There are 108 resources available
Q&A and live discussion
Presenter: Winette Van Der Graaf
Session: Proffered Paper - Sarcoma
Resources:
Webcast
Invited Discussant LBA72 and LBA73
Presenter: Emanuela Romano
Session: Proffered Paper - SARS-CoV-2 and cancer 2
Resources:
Slides
Webcast
Invited Discussant LBA74 and LBA75
Presenter: Antonio Passaro
Session: Proffered Paper - SARS-CoV-2 and cancer 2
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Antonio Passaro
Session: Proffered Paper - SARS-CoV-2 and cancer 2
Resources:
Webcast
Invited Discussant 524O, 525O and 526O
Presenter: Antoine Italiano
Session: Proffered Paper - Developmental therapeutics
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Christophe Massard
Session: Proffered Paper - Developmental therapeutics
Resources:
Webcast
Invited Discussant 527O and 528O
Presenter: Giulio Draetta
Session: Proffered Paper - Developmental therapeutics
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Christophe Massard
Session: Proffered Paper - Developmental therapeutics
Resources:
Webcast
LBA3_PR - An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683
Presenter: Cécile Le Pechoux
Session: Presidential Symposium II
Resources:
Abstract
Slides
Webcast
LBA4 - IPATential150: Phase III study of ipatasertib (ipat) plus abiraterone (abi) vs placebo (pbo) plus abi in metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Johann de Bono
Session: Presidential Symposium II
Resources:
Abstract
Slides
Webcast